Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06633029 · ClinicalTrials.gov registry record
Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry
A clinical trial of Acute Kidney Injury (AKI) and Fluid Overload in Dialysis Patients, sponsored by Vantive Health.
- Completed
- Registry status
- 59
- Enrollment target
- 5
- Study locations
NCT06633029 is a study of Acute Kidney Injury (AKI) and Fluid Overload in Dialysis Patients that has completed, run by Vantive Health. The registered enrollment target is 59 participants, below the 4,623-participant average among 4 other Acute Kidney Injury (AKI) trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT06633029, a study of Acute Kidney Injury (AKI) and Fluid Overload in Dialysis Patients, has completed, sponsored by Vantive Health.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
- 5
- Study locations
Study Summary
A retrospective multicenter, observational design intended to capture data on pediatrics (weighing between 8 - 20 kg) who underwent continuous renal replacement therapy (CRRT) using the HF20 set. Data will be compared with a similar population (weighting 8-20 kg) from the ppCRRT registry who received CRRT with Prismaflex M60 sets.
Conditions Studied
Interventions
- DEVICE Prismaflex HF20
Study Locations (5)
Alabama
- University of Alabama at Birmingham / Children's of Alabama - Birmingham
California
- Lucile Packard Children's Hospital Stanford - Palo Alto
Illinois
- Ann and Robert H Lurie Children's Hospital of Chicago - Chicago
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Washington
- Seattle Children's Hospital Research and Foundation - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2024-12-11 |
| Est. Completion | 2025-06-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06633029
The ClinicalTrials.gov registry entry for NCT06633029 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,623-participant average among 4 other Acute Kidney Injury (AKI) trials with a reported enrollment target (99% lower). The listed sponsor is Vantive Health, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Acute Kidney Injury (AKI) appearing as the primary indexed condition, and to 1 intervention - of which Prismaflex HF20 is the first listed.
NCT06633029 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Alabama, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT06633029 about?
NCT06633029 is a clinical study titled "Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry". A retrospective multicenter, observational design intended to capture data on pediatrics (weighing between 8 - 20 kg) who underwent continuous renal replacement therapy (CRRT) using the HF20 set. Data will be compared with a similar population (weighting 8-20 kg) from the ppCRRT registry who receive...
What is the current status of trial NCT06633029?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2024-12-11. Estimated completion is 2025-06-25.
What conditions does trial NCT06633029 study?
This clinical trial studies the following conditions: Acute Kidney Injury (AKI), Fluid Overload in Dialysis Patients, Acute Renal Failure (ARF).
What interventions are being tested in trial NCT06633029?
The interventions under investigation include: Prismaflex HF20 (DEVICE).
Who is sponsoring clinical trial NCT06633029?
This trial is sponsored by Vantive Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06633029 being conducted?
This trial has 5 study locations across Alabama, California, Illinois, Ohio, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury (AKI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
RECRUITING · Phase 3
-
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
RECRUITING · Phase 4
-
NIRS Monitoring in the NICU and AKI
RECRUITING · NA
-
Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.